Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Toronto

$105,000.00

The role of Hedgehog signaling in basal-like breast cancer and the tumour microenvironment

EF 2019-20

Résumé
Breast cancer is the most common cancer in women worldwide and remains a leading cause of cancer death. One in 9 women will develop breast cancer at some point in their lifetime. Despite the success of current treatment, breast cancer remains a potentially deadly disease with multiple subtypes that respond very differently to treatment. Basal-like breast cancer (BLBC) is a specific subtype that comprises 15% of all breast cancers and primarily affects young women, people of African or Hispanic ancestry, and those with genetic mutations. Despite current treatments, BLBC often has a poor outcome. There is therefore an unmet need for improved treatments in this group of patients. Increasing evidence has shown that the Hedgehog signaling pathway is associated with BLBC. The Hedgehog pathway is a specific molecular pathway that is essential during development of the embryo and is critical for early breast development. My preliminary studies and those of others have shown a link between activated Hedgehog signaling and the growth of breast cancer cells, with more aggressive breast cancers harboring activated Hedgehog signaling. My project will aim to study exactly how the Hedgehog pathway promotes the growth of BLBC cells. My hypothesis is that Hedgehog is responsible for releasing specific molecules that promote inflammation, termed cytokines. These cytokines then recruit immune cells that help the cancer grow and mature. By identifying which cytokines are triggered by Hedgehog signaling and which immune cells are recruited, I will then begin to test different drugs to inhibit these cytokines, thereby changing the immune cell infiltration and inhibiting cancer growth. Many of these drugs are already approved and available to treat inflammatory diseases, such as Rheumatoid Arthritis and Ulcerative Colitis. My plan would therefore be to take these drugs that have already been shown to be safe with minimal side effects, and repurpose them for use in BLBC.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
416996
Name
Marini Wanda
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
The role of Hedgehog signaling in basal-like breast cancer and the tumour microenvironment
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Immunotherapy; Oncology; Translational Research; Tumor Microenvironment
Abstract
Breast cancer is the most common cancer in women worldwide and remains a leading cause of cancer death. One in 9 women will develop breast cancer at some point in their lifetime. Despite the success of current treatment, breast cancer remains a potentially deadly disease with multiple subtypes that respond very differently to treatment. Basal-like breast cancer (BLBC) is a specific subtype that comprises 15% of all breast cancers and primarily affects young women, people of African or Hispanic ancestry, and those with genetic mutations. Despite current treatments, BLBC often has a poor outcome. There is therefore an unmet need for improved treatments in this group of patients. Increasing evidence has shown that the Hedgehog signaling pathway is associated with BLBC. The Hedgehog pathway is a specific molecular pathway that is essential during development of the embryo and is critical for early breast development. My preliminary studies and those of others have shown a link between activated Hedgehog signaling and the growth of breast cancer cells, with more aggressive breast cancers harboring activated Hedgehog signaling. My project will aim to study exactly how the Hedgehog pathway promotes the growth of BLBC cells. My hypothesis is that Hedgehog is responsible for releasing specific molecules that promote inflammation, termed cytokines. These cytokines then recruit immune cells that help the cancer grow and mature. By identifying which cytokines are triggered by Hedgehog signaling and which immune cells are recruited, I will then begin to test different drugs to inhibit these cytokines, thereby changing the immune cell infiltration and inhibiting cancer growth. Many of these drugs are already approved and available to treat inflammatory diseases, such as Rheumatoid Arthritis and Ulcerative Colitis. My plan would therefore be to take these drugs that have already been shown to be safe with minimal side effects, and repurpose them for use in BLBC.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Marini, Wanda
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~